Who Paid My Doc
Jose Bouffard
Nuclear Imaging & Therapy Detroit, MI Medical Doctor
NPI 1043388788 CMS profile 138613
261 Mack Ave, Room 215, Detroit, MI 48201
General payments
$71,260
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Jose Bouffard of Detroit, MI is reported in the CMS Open Payments database as having received $71,260 across 35 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $9,083 | 19 | |
| 2024 | General | $14,774 | 6 | |
| 2023 | General | $19,323 | 4 | |
| 2022 | General | $9,170 | 3 | |
| 2020 | General | $9,315 | 1 | |
| 2019 | General | $9,595 | 2 |
Beside peers
- Jose Bouffard
- Nuclear Imaging & Therapy median
- Middle half of Nuclear Imaging & Therapy
- National median
In program year 2025, general payments to Jose Bouffard were reported at $9,083. Among 36 Nuclear Imaging & Therapy profiles paid that year, the median was $122 and the middle half received between $44 and $626.
Show as a table
| Year | Jose Bouffard | Nuclear Imaging & Therapy median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $9,595 | $125 | $75–$435 | $163 |
| 2020 | $9,315 | $115 | $38–$1,233 | $114 |
| 2021 | $0 | $62 | $16–$343 | $132 |
| 2022 | $9,170 | $123 | $47–$287 | $149 |
| 2023 | $19,323 | $106 | $56–$169 | $160 |
| 2024 | $14,774 | $62 | $21–$161 | $164 |
| 2025 | $9,083 | $122 | $44–$626 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 45 billing codesPaid by Medicare
$6,854
Medicare patients
201
Services billed
233
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 48% | |
| Ischemic heart disease | 36% | |
| Chronic kidney disease | 32% | |
| Heart failure | 30% | |
| Depression | 28% | |
| COPD | 26% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
35 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Nuclear Imaging & Therapy in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Nuclear Imaging & Therapy
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.